Cardiovascular complications are rare in severe COVID-19 presenting with myocardial injury
Preprint
Abstract
Background: SARS-COV2 infection has been linked to cardiovascular complications. Previously published data suggested that cardiac injury may be a common disease feature and contribute to morbidity and mortality in severe COVID-19. Since the early days of the pandemic, little data has emerged describing what cardiovascular complications arise from myocardial injury in severe COVID-19 and whether these complications contribute to mortality. Objectives: Describe the incidence and nature of cardiovascular complications in patients with severe COVID-19 infection and biochemical or imaging evidence of myocardial injury. Methods: We analyzed consecutive patients admitted for severe COVID-19 and presenting with biochemical or echocardiographic evidence of myocardial injury across 16 centers within the CARDIO-COVID investigator-initiated consortium. A light-GBM machine learning model was used to identify variables associated with mortality. Results: Our study included 1,328 patients. In hospital mortality was 29.4%. Factors most associated with mortality were age, SOFA Cardiovascular score, elevated troponin, intubation, high vasoactive-inotropic score (VIS), high PEEP, and high FiO2. Cardiovascular complications were rare and did not present significant association with mortality. Patients with high VIS and SOFA Cardiovascular scores had a significantly higher incidence of secondary bacterial pneumonias suggesting septic shock played a role in their physiology. Investigator-adjudicated cause of death data identified respiratory failure and septic shock as primary causes of mortality. Conclusions: Cardiovascular complications of severe COVID-19 are uncommon and do not seem to contribute significantly to mortality. Biochemical markers of myocardial injury or strain still carry significant prognostic value, but the value of these markers may indicate presence of high-risk ARDS phenotypes as opposed to significant myocardial injury.Keywords
This publication has 27 references indexed in Scilit:
- Acute and Post-Acute COVID-19 Cardiovascular Complications: A Comprehensive ReviewCardiovascular Drugs and Therapy, 2023
- Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysisThe Lancet Respiratory Medicine, 2022
- Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registryAging Clinical and Experimental Research, 2021
- Heart Failure in COVID-19: The Multicentre, Multinational PCHF-COVICAV RegistryESC Heart Failure, 2021
- Application of subject-specific adaptive mechanical loading for bone healing in a mouse tail vertebral defectScientific Reports, 2021
- Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinationsCardiovascular Pathology, 2021
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- SLIM: Simultaneous Logic-in-Memory Computing Exploiting Bilayer Analog OxRAM DevicesScientific Reports, 2020
- From local explanations to global understanding with explainable AI for treesNature Machine Intelligence, 2020